Abstract:Rationally designed liposomes could improve the therapeutic indexes of chemotherapeutic drugs, which is due to alterations in the pharmacokinetics and biodistribution of encapsulated drugs. For traditional drug delivery systems, the accumulation of drugs in healthy and malignant tissues could be correlated with toxicity and efficacy. Some previous studies also indicate that the higher tumor AUC, the better therapeutic efficacy, suggestive of the possible existence of positive correlation. Are AUC values of liposomal drugs really predictive? For the purpose to address this question, we designed two pegylated liposomal doxorubicin formulations (PLD-75 and PLD-100), which had the same lipid/drug ratio and bilayer composition, but different size and internal ammonium sulfate concentration. In vitro drug retention experiments revealed that drug was released at a faster rate from PLD-75, a small size formulation. The plasma phan-nacokinetics of PLD-75 was similar to that of PLD- 100, regardless of whether the mice were tumor-free or not. It should be noted, though, that in tumor-bearing mice the plasma doxorubicin level in PLD-75 group was only about 59% of that in PLD-100 group at 48 h post injection. Furthermore, their biodistribution behavior in S-180 tumor-bearing KM mice was significantly different. Compared with animals receiving PLD-100, those receiving PLD-75 showed a 19.2%, 27.8%, and 23.5% decrease in liver (p < 0.0 1), spleen (p < 0.00 1) and lung (p < 0.05) AUC, respectively. In other healthy tissues except kidney, the drug deposition also reduced by 10-15%, but the difference was not significant. The tumor AUC after administration of PLD-100 and PLD-75 were 1285.3 ugh/g and 762.0 ugh/g, respectively (p < 0.001). Maximum drug levels achieved in the tumors were 33.80 mu g/g (for PLD-100) and 20.85 mu g/g (for PLD-75), and peak tumor concentration was achieved faster in PLD-75 group. However, enhanced drug accumulation does not mean increased antineoplastic effect, and at the same doxorubicin dose level, PLD-75 was more efficacious. As for toxicity studies, PLD-75 caused more rapid and severe body weight loss despite the fact that drug accumulation in healthy tissues was reduced. Our data indicate that liposomal systems are more complicated than conventional drug delivery systems, and it is hard to predict the toxicity and efficacy of liposomal drugs through the measure of liposomal drug accumulation. (c) 2006 Elsevier B.V All rights reserved.

Comparison of the effect of percutaneous intervertebral foramen injection of doxorubicin or pegylated liposome doxorubicin on hind limb behavior in rats

The efficacy and cardiac toxicity of different-dose pegylated liposomal doxorubicin in elderly patients with diffuse large B lymphoma.

Effect of intraperitoneal injection of Lidocaine on expression of NMDAR1 in spinal dorsal horn of a rat model of incisional pain

Effects of Intrathecal Morphine on Excitatory Amino Acid Contents of Spinal Cord in a Rat Model of Incision Pain

Comparable Efficacy and Less Toxicity of Pegylated Liposomal Doxorubicin Versus Epirubicin for Neoadjuvant Chemotherapy of Breast Cancer: a Case-Control Study

High-Performance Liquid Chromatography (HPLC) Quantification of Liposome-Delivered Doxorubicin in Arthritic Joints of Collagen-Induced Arthritis Rats

EFFECTS OF INTRAPERITONEAL INJECTION OF FLURBIPROFEN AXETIL ON OF BONE CANCER PAIN IN RATS

Comparison of the antitumour activity between stealth liposomal doxorubicin and regular liposomal doxorubicin

Effects of Intrathecally Coadministered Dexamethasone and Spironolactone on Pain Behaviors in a Rat Model of Radicular Pain

The Effects of Intraperitoneal Lithium Chloride Injection on Pain Behaviors in a Rat Model of Radicular Pain

THE ANALGESIC EFFECTS OF INTRATHECAL ADMINISTRATION OF Ro 25-6981 ON NEUROPATHIC PAIN IN RATS:STUDY ON THE ELECTROPHYSIOLOGICAL MECHANISMS

Analgesia effects of intrathecally coadministered dexamethasone and Alt inhibitors on chronic dorsal root ganglion compression-induced pain in mouse

Direct Comparison of Two Pegylated Liposomal Doxorubicin Formulations: is AUC Predictive for Toxicity and Efficacy?

EFFECTS OF α-LIPOIC ACID ON PACLITAXEL INDUCED PERIPHERAL NEUROPATHY in RATS

Effect of intrathecal injection of dexamethasone on expression of substance P and calcitonin gene-related peptide in spinal cord of rats with chronic constrictive injury-induced neuropathic pain

Reexamining the effects of drug loading on the in vivo performance of PEGylated liposomal doxorubicin

Impact of intraperitoneal injection of yohimbine, an a2 receptor antagonist, on the analgesia effect of dezocine in SD rats

A pegylated liposomal platform: pharmacokinetics, pharmacodynamics, and toxicity in mice using doxorubicin as a model drug.

The Efects of Intrathecal Administration of Cyclin-Dependent Kinase 5 Inhibitor Roscovitine on the Pain Behavior of CCD Rats

Effect of Repeated Intrathecal Injection of Ifenprodil on Pain Behaviors in Mice with Bone Cancer Pain

The Analgesic Effects of Intrathecal Administration of Ro 25-6981 on Incision Pain in Rats